Pradigastat

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NamePradigastat
Drug Alias NamePradigastatum普加司他普拉司他LCQ908-NXALCQ-908 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDiacylglycerol O-acyltransferase 1 inhibitors
TargetsDiacylglycerol O-acyltransferase 1
Therapy Area/IndicationsConstipationHypertriglyceridemiaHyperlipoproteinemias +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesPoland +[13] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesAnji PharmaceuticalsAnji Pharma （US） LLCAnji Pharma (Shanghai) Ltd +[4] 
Inactive CompaniesNovartis Pharma Ag
Active IndicationsConstipation
Inactive IndicationsHypertriglyceridemiaHyperlipoproteinemiasDiabetes Mellitus, Type 2 +[9] 

Other Information

ATC CodeN/A
Related LinksKEGG